Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Yuka Kawaji"'
Autor:
Yuka Kawaji-Kanayama, Taku Tsukamoto, Masakazu Nakano, Yuichi Tokuda, Hiroaki Nagata, Kentaro Mizuhara, Yoko Katsuragawa-Taminishi, Reiko Isa, Takahiro Fujino, Yayoi Matsumura-Kimoto, Shinsuke Mizutani, Yuji Shimura, Masafumi Taniwaki, Kei Tashiro, Junya Kuroda
Publikováno v:
HemaSphere, Vol 7, p e0595036 (2023)
Externí odkaz:
https://doaj.org/article/7f65d70361e148a7b17fa48f78cdaf49
Autor:
Yuka Kawaji‐Kanayama, Tsutomu Kobayashi, Ayako Muramatsu, Hitoji Uchiyama, Nana Sasaki, Nobuhiko Uoshima, Mitsushige Nakao, Ryoichi Takahashi, Kazuho Shimura, Hiroto Kaneko, Miki Kiyota, Katsuya Wada, Yoshiaki Chinen, Koichi Hirakawa, Shin‐ichi Fuchida, Chihiro Shimazaki, Yayoi Matsumura‐Kimoto, Shinsuke Mizutani, Taku Tsukamoto, Yuji Shimura, Shigeo Horiike, Masafumi Taniwaki, Junya Kuroda, Kyoto Clinical Hematology Study Group (KOTOSG) Investigators
Publikováno v:
Cancer Reports, Vol 5, Iss 2, Pp n/a-n/a (2022)
Abstract Background Combinatory strategies with carfilzomib (CFZ), a second‐generation proteasome inhibitor, plus dexamethasone (DEX) with or without lenalidomide (LEN) have shown promising efficacy for patients with relapsed/refractory multiple my
Externí odkaz:
https://doaj.org/article/bdff3f7ce0164c809dccfaff7fdd38f3
Autor:
Yayoi Matsumura‐Kimoto, Taku Tsukamoto, Yuji Shimura, Yoshiaki Chinen, Kazuna Tanba, Saeko Kuwahara‐Ota, Yuto Fujibayashi, Daichi Nishiyama, Reiko Isa, Junko Yamaguchi, Yuka Kawaji‐Kanayama, Tsutomu Kobayashi, Shigeo Horiike, Masafumi Taniwaki, Junya Kuroda
Publikováno v:
Cancer Medicine, Vol 9, Iss 14, Pp 5185-5199 (2020)
Abstract RSK2 is a serine/threonine kinase downstream signaling mediator in the RAS/ERK signaling pathway and may be a therapeutic target in mantle cell lymphoma (MCL), an almost incurable disease subtype of non‐Hodgkin lymphoma. In this study, ser
Externí odkaz:
https://doaj.org/article/9e1e7146637b4917811ff4b9c406b974
Autor:
Reiko Isa, Mano Horinaka, Taku Tsukamoto, Kentaro Mizuhara, Yuto Fujibayashi, Yoko Taminishi-Katsuragawa, Haruya Okamoto, Shusuke Yasuda, Yuka Kawaji-Kanayama, Yayoi Matsumura-Kimoto, Shinsuke Mizutani, Yuji Shimura, Masafumi Taniwaki, Toshiyuki Sakai, Junya Kuroda
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 6, p 2919 (2022)
Multiple myeloma (MM) is characterized by remarkable cytogenetic/molecular heterogeneity among patients and intraclonal diversity even in a single patient. We previously demonstrated that PDPK1, the master kinase of series of AGC kinases, is universa
Externí odkaz:
https://doaj.org/article/9d2711c457da42ed8552ce81b87ea074
Autor:
Junko Yamaguchi, Takahiro Fujino, Reiko Isa, Daichi Nishiyama, Saeko Kuwahara-Ota, Yuka Kawaji, Taku Tsukamoto, Yoshiaki Chinen, Yuji Shimura, Tsutomu Kobayashi, Shigeo Horiike, Kei Kohno, Shigeo Nakamura, Junya Kuroda
Publikováno v:
Haematologica, Vol 104, Iss 8 (2019)
Externí odkaz:
https://doaj.org/article/65fc80779c1d4266a977513eb1b533d7
Autor:
Yuka Kawaji-Kanayama, Taku Tsukamoto, Masakazu Nakano, Yuichi Tokuda, Hiroaki Nagata, Kentaro Mizuhara, Yoko Katsuragawa-Taminishi, Reiko Isa, Takahiro Fujino, Yayoi Kimoto-Matsumura, Shinsuke Mizutani, Yuji Shimura, Masafumi Taniwaki, Kei Tashiro, Junya Kuroda
B-cell receptor (BCR) signaling is critically activated and targetable for mantle cell lymphoma (MCL); however, the underlying mechanism of the activated BCR signaling pathway is not clear. The pathogenic basis of miR-17-92 cluster remains unclear al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9761b577238c41562062abf8098aacb
https://doi.org/10.21203/rs.3.rs-2496311/v1
https://doi.org/10.21203/rs.3.rs-2496311/v1
Autor:
Haruya Okamoto, Yu Inoue, Akihiro Miyashita, Yuka Kawaji-Kanayama, Shotaro Chinen, Takahiro Fujino, Taku Tsukamoto, Yuji Shimura, Shinsuke Mizutani, Hiroto Kaneko, Saeko Kuwahara, Shin-ichi Fuchida, Daichi Nishiyama, Koichi Hirakawa, Junya Kuroda
Publikováno v:
Blood. 140:12321-12322
Autor:
Kentaro Mizuhara, Yuji Shimura, Taku Tsukamoto, Akinori Kanai, Saeko Kuwahara-Ota, Junko Yamaguchi, Ayako Muramatsu, Haruya Okamoto, Yoko Katsuragawa-Taminishi, Yuka Kawaji-Kanayama, Reiko Isa, Shinsuke Mizutani, Toshiya Inaba, Junya Kuroda
Publikováno v:
Blood. 140:9949-9950
Autor:
Ayako, Muramatsu, Tsutomu, Kobayashi, Yuka, Kawaji-Kanayama, Hitoji, Uchiyama, Nana, Sasaki, Nobuhiko, Uoshima, Mitsushige, Nakao, Ryoichi, Takahashi, Kazuho, Shimura, Hiroto, Kaneko, Miki, Kiyota, Katsuya, Wada, Yoshiaki, Chinen, Koichi, Hirakawa, Shin-Ichi, Fuchida, Chihiro, Shimazaki, Shinsuke, Mizutani, Taku, Tsukamoto, Yuji, Shimura, Masafumi, Taniwaki, Satoshi, Teramukai, Junya, Kuroda
Publikováno v:
Leukemialymphoma. 63(7)
Carfilzomib (CFZ) constitutes powerful combinatory therapy for relapsed/refractory multiple myeloma (RRMM); however, cardiovascular adverse events (CVAEs) have been shown as major treatment obstacles with the use of CFZ. Along with our multi-institut
Autor:
Shigeru Hirano, Shota Okamoto, Gaku Ohmura, Taku Tsukamoto, Junya Kuroda, Yuji Shimura, Yuka Kawaji-Kanayama, Ayako Nishimura, Kazutoshi Shibuya, Eiichi Konishi, Tsutomu Kobayashi, Shinsuke Mizutani, Makoto Yasuda, Emiko Sakiyama
Publikováno v:
Infection and Drug Resistance. 13:3225-3232
Invasive fungal rhinosinusitis (FRS) is a rare but intractable infectious disease of the sinonasal region with destructive direct infiltration into surrounding tissues, such as the bone, orbit and brain, and potential dissemination to systemic organs